Floatz logo

SL-28

Head And Neck Cancer

Second Life TherapeuticsUNKNOWNPhase 1/2Active
CC
47/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
33/ 100
Competitive Position
89/ 100

Competitive context

141 Active assets in the Head And Neck Cancer cohort.

Asset / SponsorPhaseRating
NEPENTHE
Instituto Nacional de Cancer, Brazil
Phase 4BB
CIS-DIAMMINEDICHLOROPLATINUM II
ImmunityBio, Inc.
Phase 3BB
Lidocaine
Instituto Nacional de Cancer, Brazil
Phase 3BB
Carboplatin
Rapa Therapeutics LLC
Phase 3BB
Cyclophosphamide
Zelluna Immunotherapy AS
Phase 3BB

View all 50 →

Same molecule, other indications

SL-28 is also rated in:

intestinal cancerActive
CCC
Indicative · Phase 1/2
48 / 100
View asset →
malignant pancreatic neoplasmActive
CC
Indicative · Phase 1/2
47 / 100
View asset →
non-small cell lung carcinomaActive
CC
Indicative · Phase 1/2
45 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →